MRK
Merck & Co., Inc.
NYSE · USHealthcareDrug Manufacturers - General
$124.41-2.42%
Price as of Jul 20, 2026
MRK profitability
Merck & Co., Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 75.9%
- EBITDA margin
- 28.6%
- EBIT margin
- 27.6%
- Net margin
- 13.6%
- Free cash flow margin
- 21.5%
Returns
- Return on equity
- 19.5%
- Return on assets
- 6.9%
- Return on invested capital
- 19.1%
- Asset turnover
- 0.49x
Cash efficiency
- Cash from operations
- $17.9B
- Cash per share
- $2.31
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.